Gastroenterology
13/08/2019 - C.difficile becoming two species
Clostridium difficile is evolving into two distinct species – and one is "highly adapted" to spreading in hospitals, researchers warn today. More
09/07/2019 - Immunotherapy hope for bowel cancer patients
Immunotherapy could benefit people who have stopped responding to a bowel cancer drug, according to a major new study. More
08/07/2019 - Combination therapy improves advanced bowel cancer survival rates
A combination of targeted therapies can improve survival in patients with advanced bowel cancer and should replace chemotherapy, new data has revealed. More
01/07/2019 - Ulcerative colitis two diseases
Genetic analysis has enabled doctors to divide ulcerative colitis into two types of disease, which respond differently to drugs, it has been announced. More
22/05/2019 - New gene test for bowel cancer subtype
A test has been unveiled that enables clinicians making a diagnosis of bowel cancer to identify which of five sub-types is involved. More
25/03/2019 - Drug that could tackle bowel cancer drug-resistance
British scientists have identified a third drug that could help tackle resistance to treatment when bowel cancer is treated with the latest therapies, it was announced today. More
03/01/2019 - Cancer breath test project launched
Ambitious plans to develop a single breath test for multiple cancers were announced today. More
28/11/2018 - Colorectal cancer treatment delayed for up to a year
Some patients with colorectal cancer do not begin treatment until a year after they first notice symptoms, researchers warn today. More
20/11/2018 - Common substances may reduce bowel polyp risk
Both aspirin and fish oil can improve the prospects for people at high risk of developing bowel cancer, according to the findings of a major UK study published today. More
15/11/2018 - Drug combination for neuroblastoma?
A new drug combination has shown “highly significant” results in laboratory tests on neuroblastoma, a European conference will hear today. More
14/11/2018 - HER2 cancers respond well to new drug
People with cancers of the oesophagus, stomach and colon have experienced positive results from a new anti-HER2 drug, a European conference is being told today. More
01/11/2018 - Appendix a source of Parkinson's?
People who have undergone appendectomy as children face a reduced risk of developing Parkinson’s disease, according to the findings of a major study in Sweden. More
31/10/2018 - Obesity link to early antibiotics
Children who are given antibiotics and antacids in early life may face an increased risk of becoming obese, researchers warn today. More
25/10/2018 - Antibiotics, the 'avoidable trigger' for bowel disease
A high fibre diet should be followed when taking antibiotics because the drugs can predispose the gut to avoidable infections that trigger bowel disease in mice. More
06/08/2018 - New stem cell trial for Crohn's patients
A new UK trial is to test the use of stem cell transplants to grow new immune systems for people with untreatable Crohn’s disease, was announced today. More
17/07/2018 - Bowel screening may reveal other diseases
The UK screening programme for bowel cancer may be identifying people at risk from a range of other diseases, researchers say today. More
01/06/2018 - Antifungal drug could halt dormant bowel cancer cells
A treatment used for toenail problems could be used to help eliminate dormant cells within bowel tumours, new research has unveiled. More
22/05/2018 - Link between IBD and Parkinson's
People with inflammatory bowel disease face an increased risk of developing Parkinson's disease, Danish researchers report today. More
19/03/2018 - Colorectal cancer mortality rates falling – European analysis
Europe has achieved major progress in reducing mortality from colorectal cancer, experts say today. More
12/03/2018 - Drink rather than vaccine may be cholera answer
A fast-acting, drinkable antidote for cholera epidemics is getting closer to being developed, according to two new studies. More
Printer friendly page